Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

0.0%

0 terminated/withdrawn out of 24 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

25%

6 trials in Phase 3/4

Results Transparency

6%

1 of 16 completed trials have results

Key Signals

1 recruiting1 with results

Enrollment Performance

Analytics

N/A
13(65.0%)
Phase 4
5(25.0%)
Phase 2
1(5.0%)
Phase 3
1(5.0%)
20Total
N/A(13)
Phase 4(5)
Phase 2(1)
Phase 3(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (24)

Showing 20 of 24 trials
NCT03783429Phase 4Completed

Digoxin Evaluation in Chronic Heart Failure: Investigational Study In Outpatients in the Netherlands

Role: collaborator

NCT07105241Not ApplicableNot Yet Recruiting

Virtual Reality in Electrophysiological Procedures and Device Implantation: the VR inEP Trial

Role: collaborator

NCT05776212Recruiting

Quantitative-imaging in Cardiac Transthyretin Amyloidosis

Role: collaborator

NCT05348460Not ApplicableCompleted

Effects of a Single Oral Dose of KETone Ester ON Exercise Performance in Patients With Chronic Heart Failure

Role: collaborator

NCT01510210Unknown

Risk Profile for Patients With Atrial Fibrillation

Role: collaborator

NCT05460572Not ApplicableUnknown

Cardiac Metabolic Profiling in the Fed State

Role: collaborator

NCT00877643Not ApplicableCompleted

Routine Versus Aggressive Upstream Rhythm Control for Prevention of Early Atrial Fibrillation in Heart Failure

Role: collaborator

NCT01091389Phase 4Completed

Atrial Fibrillation Ablation and Autonomic Modulation Via Thorascopic Surgery

Role: collaborator

NCT03073018Phase 3Completed

Prevention of Renal and Vascular Endstage Disease Intervention Trial

Role: collaborator

NCT01613794Not ApplicableCompleted

Rosuvastatin Use to Improve the Coagulation Profile in Patients With Venous Thrombosis

Role: collaborator

NCT01114074Unknown

Thrombus Formation Under Different Flow-conditions

Role: collaborator

NCT00866801Completed

Coronary Blood Flow Regulation During General Anesthesia

Role: collaborator

NCT02014961Not ApplicableUnknown

Worm Study: Modifier Genes in Sudden Cardiac Death

Role: collaborator

NCT01379079Phase 4Completed

Aspirin in Reduction of Tension II Study

Role: collaborator

NCT00138034Phase 4Completed

APRICOT-3: Antithrombotics in the Prevention of Reocclusion In COronary Thrombolysis -3

Role: collaborator

NCT00127452Not ApplicableCompleted

Alpha Omega Trial: Study of Omega-3 Fatty Acids and Coronary Mortality

Role: collaborator

NCT00122213Phase 2Completed

A Physical Activity and Diet Program to Prevent Accumulation of Abdominal Fat Mass in Recently Retired Men and Women

Role: collaborator

NCT00149422Not ApplicableCompleted

Effect of NT-proBNP Guided Treatment of Chronic Heart Failure

Role: lead

NCT00392613Not ApplicableCompleted

RAte Control Efficacy in Permanent Atrial Fibrillation

Role: collaborator

NCT01013038Phase 4Unknown

Thrombus Aspiration During Percutaneous Coronary Intervention in Acute Non-ST-elevation Myocardial Infarction Study

Role: collaborator